Literature DB >> 8410274

Optimization of radioiodine therapy of thyrotoxicosis: what have we learned after 50 years?

B Shapiro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8410274

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  15 in total

1.  Value of ethanol injection in the treatment of the autonomous thyroid nodule.

Authors:  C Ferrari
Journal:  J Endocrinol Invest       Date:  1995-06       Impact factor: 4.256

Review 2.  Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma.

Authors:  Massimo Salvatori; Markus Luster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-04       Impact factor: 9.236

Review 3.  An overview of translational (radio)pharmaceutical research related to certain oncological and non-oncological applications.

Authors:  Marlein Miranda Cona; Peter de Witte; Alfons Verbruggen; Yicheng Ni
Journal:  World J Methodol       Date:  2013-12-26

4.  Late and transient increases in free T4 after radioiodine treatment for Graves' disease.

Authors:  A D Stensvold; R Jorde; J Sundsfjord
Journal:  J Endocrinol Invest       Date:  1997-11       Impact factor: 4.256

5.  Dose-response study on thyrotoxic patients undergoing positron emission tomography and radioiodine therapy.

Authors:  M A Flower; A al-Saadi; C L Harmer; V R McCready; R J Ott
Journal:  Eur J Nucl Med       Date:  1994-06

6.  Ultrasonography thyroid volume estimation in hyperthyroid patients treated with individual radioiodine dose.

Authors:  F Massaro; L Vera; M Schiavo; C Lagasio; M Caputo; M Bagnasco; F Minuto; M Giusti
Journal:  J Endocrinol Invest       Date:  2007-04       Impact factor: 4.256

7.  Radioiodine I-131 for the therapy of graves' disease.

Authors:  Malik Mumtaz; Lim Shueh Lin; Khaw Chong Hui; Amir Sharifuddin Mohd Khir
Journal:  Malays J Med Sci       Date:  2009-01

8.  The occurrence of hypothyroidism following radioactive iodine treatment of toxic nodular goiter is related to the TSH level.

Authors:  H I Adamali; J Gibney; D O'Shea; M Casey; T J McKenna
Journal:  Ir J Med Sci       Date:  2007-07-14       Impact factor: 1.568

9.  Radioiodine treatment of hyperthyroidism: prognostic factors affecting outcome.

Authors:  Cihangir Erem; Nurten Kandemir; Arif Hacihasanoglu; Halil Onder Ersöz; Kubilay Ukinc; Mustafa Kocak
Journal:  Endocrine       Date:  2004-10       Impact factor: 3.633

10.  Radioiodine thyroid ablation in graves' hyperthyroidism: merits and pitfalls.

Authors:  J F Nwatsock; D Taieb; L Tessonnier; J Mancini; F Dong-A-Zok; O Mundler
Journal:  World J Nucl Med       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.